Le-Mantus Pharmaceuticals Private Limited, a active private limited company, was established on 24 January 2006 in Delhi, Delhi, India. Engaging in animal pharmaceuticals & healthcare within the trade sector, it holds CIN: U24233DL2006PTC145303. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹6.00 M and a paid-up capital of ₹2.50 M.
It upholds a compliant status. Its leadership includes Asha Jain (Director), Ashutosh Gupta (Director), Annu Gupta (Director). Past directors included Ravinder Gupta, Asha Jain, Ashutosh Gupta. It holds ₹9.99 Cr open charges and ₹10.31 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 25 Shivam Apttssector 15 Rohini Delhi, Delhi, Delhi.
U24233DL2006PTC145303
145303
24 January 2006
₹6.00 M
₹2.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Le-Mantus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Asha Jain | Director | 13 Jul 2017 | Current |
| Ashutosh Gupta | Director | 07 Jul 2010 | Current |
| Annu Gupta | Director | 07 Jul 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Jul 2010 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 20 Aug 2010 | Past |
| Pramod Abcsdd | Director | 30 Jul 2010 | Past |
| Pramod Abcsdd | Additional Director | 20 Aug 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Le-Mantus Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.6% increase. The company also saw a substantial fall in profitability, with a 28.44% decrease in profit. The company's net worth Soared by an impressive increase of 25%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Le-Mantus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹99,925,000.00
₹103,081,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jun 2024 | Others | ₹9.99 Cr | Open |
| 28 Jul 2018 | Others | ₹6.34 Cr | Satisfied |
| 07 Feb 2017 | Others | ₹2.52 Cr | Satisfied |
| 04 Oct 2012 | Hdfc Bank Limited | ₹9.50 M | Satisfied |
| 12 Nov 2011 | Punjab National Bank | ₹5.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Le-Mantus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Le-Mantus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Le-Mantus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others of Rs. 99.93 M registered on 11 Jun 2024 with Charge ID 100955045 was modified on 08 Oct 2025. was documented.
Progress on Le-Mantus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
A charge registered on 28 Jul 2018 via Charge ID 100229031 with Others was fully satisfied on 20 Jul 2024. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 99.93 M with Charge ID 100955045 was registered on 11 Jun 2024. was completed.
The activity Le-Mantus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Progress on A charge with Others of Rs. 63.43 M registered on 28 Jul 2018 with Charge ID 100229031 was modified on 23 Jan 2023. was documented.
The CIN of Le-Mantus Pharmaceuticals Private Limited is U24233DL2006PTC145303.
Le-Mantus Pharmaceuticals Private Limited is headquartered at 25 Shivam Apttssector 15 Rohini Delhi, Delhi, Delhi.
Le-Mantus Pharmaceuticals Private Limited was incorporated on 24 January 2006.
The current directors of Le-Mantus Pharmaceuticals Private Limited are
The primary industry of Le-Mantus Pharmaceuticals Private Limited is Trade.
Le-Mantus Pharmaceuticals Private Limited is unlisted.
The authorized capital of Le-Mantus Pharmaceuticals Private Limited is ₹6.00 M, and the paid-up capital is ₹2.50 M.
The compliance status of Le-Mantus Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX